91%
Finnrick rating
#2 of 250 Retatrutide vendors
14 of 14 classifiable tests passed
natural 100% · customers 4.7★ (26)
methodology · Purity focus
Finnrick analysis · Retatrutide

Fill trends low, including -16% and -14%, and two tests lack batch identifiers for Inno Peptides Retatrutide. Repeated 99.9% purity and identity passes keep the purity-focused profile low-concern.

methodology →
vendor intelligence report
Vendor Intelligence Report: Inno Peptides

Corporate archives tie Inno Peptides to a Wuhan chemical-export network, while domain records show a renewed but parked storefront and continuing DM sales. The report separates it from the similarly named InnoPeptide and traces counterfeit-HGH, impersonation, and payment-recourse signals.

30 pages6 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
91%
5
2
Retatrutideselected
$1.00
91%
15
3
Tirzepatide
$0.40
82%
8
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%2 Mar 2026: 78%4 Mar 2026: 79%19 Mar 2026: 82%28 Apr 2026: 83%5 May 2026: 84%11 May 2026: 85%5 Jun 2026: 86%26 Jun 2026: 87%26 Jun 2026: 88%15 Jul 2026: 89%17 Jul 2026: 89%3 Aug 2026: 90%4 Aug 2026: 91%4 Aug 2026: 91%9 Aug 2026: current 91%78%83%91%Mar 26Aug 26
Showing Retatrutide tests only
Inno Peptides Retatrutide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
4 Aug 2026Pass
Tested
lab nameView COA
4 Aug 2026Pass
Tested
lab nameView COA
3 Aug 2026Pass
Tested
lab nameView COA
17 Jul 2026Pass
Tested
lab nameView COA
15 Jul 2026Pass
Tested
lab nameView COA
26 Jun 2026Pass
Tested
lab nameView COA
26 Jun 2026Incomplete
Tested
lab nameView COA
26 Jun 2026Pass
Tested
lab nameView COA
5 Jun 2026Pass
Tested
lab nameView COA
11 May 2026Pass
Tested
lab nameView COA
1-10 of 15

About Inno Peptides test results from Finnrick

Inno Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 28 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Inno Peptides peptides in this dataset are Retatrutide (15 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 28 recent tests.

Corrections
No corrections.